Back to Search
Start Over
Supplementary Tables from Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia
Supplementary Tables from Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Table S1 details the IWG response criteria for MDS/MPNs. Supplementary Table S2 summarizes grade 3 and 4 treatment-emergent toxicities. Supplementary Table S3 summarizes all recorded adverse events. Supplementary Table S4 summarizes the reasons for treatment discontinuation. Supplementary Table S5 details the baseline characteristics of patients from which patient-derived xenograft mice were generated.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....546a01d27e36ac313485050cabac7a27
- Full Text :
- https://doi.org/10.1158/1078-0432.22480698.v1